CTI BioPharma Corp.

NASDAQ: CTIC · Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Revenue Breakdown

Period Ending Dec 31, 2018
License and Service Revenue 26.29M
License and Service Revenue Growth n/a
Product Revenue n/a
Product Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 21.91M 23.69M 21.5M 21.59M 18.05M 24.69M 13.66M 10.21M 7.63M 5.31M 4.05M 3.8M 4.47M 4.49M 4.4M 5.05M 5.21M 5.26M 5.65M 4.87M 5.41M 6.98M 5.8M 7.96M 10.69M 9.21M 15.22M 9.57M 11.31M 15.36M 13.68M 12.62M 12.3M
Selling, General, and Administrative Revenue Growth -7.51% +10.21% -0.43% +19.64% -26.92% +80.72% +33.79% +33.92% +43.62% +31.05% +6.72% -15.00% -0.58% +2.04% -12.86% -2.94% -1.03% -6.89% +16.12% -10.06% -22.54% +20.36% -27.13% -25.51% +16.11% -39.51% +59.00% -15.39% -26.35% +12.26% +8.38% +2.66% n/a
Research and Development Revenue 10.21M 11.92M 8.22M 8.71M 8.05M 10.68M 9.72M 9.29M 9.44M 9.49M 6.99M 6.2M 3.26M 4.98M 7.6M 6.36M 5.17M 7.93M 9.73M 9.12M 9.69M 7.1M 7.6M 8.91M 9.25M 9.7M 17.72M 16.7M 20.85M 21.43M 18.4M 19.32M 17.47M
Research and Development Revenue Growth -14.35% +45.04% -5.57% +8.16% -24.66% +9.93% +4.56% -1.60% -0.44% +35.63% +12.82% +89.92% -34.47% -34.44% +19.54% +22.89% -34.76% -18.52% +6.64% -5.79% +36.45% -6.62% -14.73% -3.66% -4.63% -45.24% +6.10% -19.90% -2.73% +16.45% -4.74% +10.58% n/a